These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 20845225)

  • 21. Coping style of schizophrenic patients in recovery from acute psychotic state.
    Yagi G; Kinoshita F; Nakamura A; Koshiishi M; Kanba S
    Yakubutsu Seishin Kodo; 1991 Feb; 11(1):75-8. PubMed ID: 1679275
    [No Abstract]   [Full Text] [Related]  

  • 22. Movement towards coherence in the psychotherapy of schizophrenia: a method for assessing narrative transformation.
    Lysaker PH; Wickett AM; Campbell K; Buck KD
    J Nerv Ment Dis; 2003 Aug; 191(8):538-41. PubMed ID: 12972857
    [No Abstract]   [Full Text] [Related]  

  • 23. Case report: Effective treatment of Cotard's syndrome: quetiapine in combination with venlafaxine.
    Chan JH; Chen CH; Robson D; Tan HK
    Psychiatry Clin Neurosci; 2009 Feb; 63(1):125-6. PubMed ID: 19154221
    [No Abstract]   [Full Text] [Related]  

  • 24. Convergence of voices: assimilation in linguistic therapy of evaluation.
    Gabalda IC
    Clin Psychol Psychother; 2009; 16(3):182-98. PubMed ID: 19363816
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacotherapy plus psychotherapy for treatment of depression in active injection drug users.
    Stein MD; Solomon DA; Herman DS; Anthony JL; Ramsey SE; Anderson BJ; Miller IW
    Arch Gen Psychiatry; 2004 Feb; 61(2):152-9. PubMed ID: 14757591
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Intensity of psychotic symptoms and selected demographic data as predictors of effectiveness of psychotherapy of schizophrenic patients in a day-hospital treatment].
    Kamiński R; Lisiecka A
    Psychiatr Pol; 2002; 36(2):211-23. PubMed ID: 12043040
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ["Psychological defense" as a compensation mechanism and its significance in the psychotherapy of schizophrenia].
    Wolowik VM; Vid VD
    Psychiatr Neurol Med Psychol (Leipz); 1978 Nov; 30(11):641-7. PubMed ID: 740797
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical predictors of acute risperidone response in schizophrenia, schizoaffective disorder, and psychotic mood disorders.
    Keck PE; Wilson DR; Strakowski SM; McElroy SL; Kizer DL; Balistreri TM; Holtman HM; DePriest M
    J Clin Psychiatry; 1995 Oct; 56(10):466-70. PubMed ID: 7559373
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Strategies for coping in schizophrenia].
    Lalonde P; Lesage A; Comtois G; Morin C; Likavcanova E; L'Ecuyer G
    Encephale; 1996; 22(4):240-6. PubMed ID: 9035980
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationships between insight and medication adherence in outpatients with schizophrenia and bipolar disorder: prospective study.
    Yen CF; Chen CS; Ko CH; Yeh ML; Yang SJ; Yen JY; Huang CF; Wu CC
    Psychiatry Clin Neurosci; 2005 Aug; 59(4):403-9. PubMed ID: 16048445
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Client experiences of helpful factors in a day treatment program: a qualitative approach.
    Mörtl K; Von Wietersheim J
    Psychother Res; 2008 May; 18(3):281-93. PubMed ID: 18815980
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessing client self-narrative change in emotion-focused therapy of depression: an intensive single case analysis.
    Angus LE; Kagan F
    Psychotherapy (Chic); 2013 Dec; 50(4):525-34. PubMed ID: 24295461
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Self-efficacy and empowerment as outcomes of self-stigmatizing and coping in schizophrenia.
    Vauth R; Kleim B; Wirtz M; Corrigan PW
    Psychiatry Res; 2007 Feb; 150(1):71-80. PubMed ID: 17270279
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Narrative change in emotion-focused psychotherapy: a study on the evolution of reflection and protest innovative moments.
    Mendes I; Ribeiro AP; Angus L; Greenberg LS; Sousa I; Goncalves MM
    Psychother Res; 2011 May; 21(3):304-15. PubMed ID: 21480051
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Comparison of 2 depression scales and their relationship with negative and akinetic symptoms in stabilized schizophrenic patients].
    Langlois-Thery S; Dollfus S; Lesieur P; Petit M
    Encephale; 1994; 20(5):487-93. PubMed ID: 7828511
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Negative symptoms, tardive dyskinesia and depression in chronic schizophrenia.
    Barnes TR; Liddle PF; Curson DA; Patel M
    Br J Psychiatry Suppl; 1989 Nov; (7):99-103. PubMed ID: 2575915
    [No Abstract]   [Full Text] [Related]  

  • 37. Lack of desipramine toxicity with citalopram.
    Ashton AK
    J Clin Psychiatry; 2000 Feb; 61(2):144. PubMed ID: 10732663
    [No Abstract]   [Full Text] [Related]  

  • 38. Quetiapine is effective against anxiety and depressive symptoms in long-term treatment of patients with schizophrenia.
    Kasper S
    Depress Anxiety; 2004; 20(1):44-7. PubMed ID: 15368596
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Current concepts of pharmacological treatment in schizophrenia].
    Jarema M
    Psychiatr Pol; 2002; 36(6):857-68. PubMed ID: 12725017
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discovering markers of assimilation stages: the fear-of-losing-control marker.
    Honos-Webb L; Lani JA; Stiles WB
    J Clin Psychol; 1999 Dec; 55(12):1441-52. PubMed ID: 10855479
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.